Rosiglitazone Versus Placebo in Chronic Stable Angina

NCT00225355 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Angina Pectoris
Metabolic Syndrome X

Interventions

DRUG: Rosiglitazone

Sponsor

University of Glasgow

Collaborators

[object Object]
[object Object]